首页 > 最新文献

Journal of global antimicrobial resistance最新文献

英文 中文
Detection of zoonotic Coxiella burnetii causing chronic Q fever endocarditis in a Chinese geriatric patient by mNGS mNGS检测中国老年人慢性Q热心内膜炎的人畜共患伯纳蒂克希菌。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-10-06 DOI: 10.1016/j.jgar.2025.09.015
Hui Wang , Jie Sheng , Ying Zhang , Hao Lan , Xiaofeng Lu , Xi Li , Xiaofei Zhao

Objective

Q (query) fever, caused by Coxiella burnetii, is often linked to negative bacterial cultures, with infective endocarditis with negative cultures difficult to diagnose and treat. Our case demonstrates that metagenomic next-generation sequencing (mNGS) is able to provide a rapid and accurate method for pathogenetic diagnosis in infectious diseases.

Case presentation

A case of infective endocarditis with negative blood cultures is reported in a male patient with a history of sheep farming and previous aortic valve replacement and atrial septal defect atrial septal defect repair. Blood tests showed positive serum immunofluorescent antibodies to Rickettsia, while mNGS of perivalvular abscess tissue suggested C. burnetii. Doxycycline 0.1 g q12h and hydroxychloroquine 0.2 g q12h were used for postoperative antibiotic treatment. The genome of C. burnetii C2245173Z was assembled on the Illumina platform and no known antibiotic resistance genes were detected. Phylogenetic analysis of the C. burnetii genome showed a genetic relationship between animal- and human-derived strains.

Conclusions

mNGS could provide a rapid and accurate assay for clinical diagnosis and play a decisive role in the pathogenetic diagnosis of some infectious diseases. Doxycycline plus hydroxychloroquine remains an effective treatment for chronic Q fever endocarditis. In addition, phylogenetic tree analysis indicates that C. burnetii infection may pose a potential risk to humans working with livestock.
目的:由伯纳氏克希菌引起的发热通常与阴性细菌培养有关。阴性培养的感染性心内膜炎很难诊断和治疗。我们的案例表明,新一代宏基因组测序(mNGS)可以为传染病的病理诊断提供快速准确的方法。病例介绍:我们报告了一例感染性心内膜炎伴阴性血培养的男性患者,有养羊史,有主动脉瓣置换术(AVT)和房间隔缺损(ASD)修复史。血液检查显示血清立克次体免疫荧光抗体阳性,而瓣膜周围脓肿组织的mNGS提示伯氏原体感染。术后应用强力霉素0.1 g q12h、羟氯喹0.2 g q12h给予抗生素治疗。在Illumina平台上组装burnetii C2245173Z基因组,未检测到已知的抗生素耐药基因。伯纳蒂胞杆菌基因组的系统发育分析显示动物源性菌株和人源性菌株之间存在遗传关系。结论:应用mNGS可为临床诊断提供快速、准确的检测方法,在某些感染性疾病的发病诊断中具有决定性作用。强力霉素加羟氯喹仍然是治疗慢性Q热心内膜炎的有效方法。此外,系统发育树分析表明,伯纳蒂胞杆菌感染可能对与牲畜一起工作的人构成潜在风险。
{"title":"Detection of zoonotic Coxiella burnetii causing chronic Q fever endocarditis in a Chinese geriatric patient by mNGS","authors":"Hui Wang ,&nbsp;Jie Sheng ,&nbsp;Ying Zhang ,&nbsp;Hao Lan ,&nbsp;Xiaofeng Lu ,&nbsp;Xi Li ,&nbsp;Xiaofei Zhao","doi":"10.1016/j.jgar.2025.09.015","DOIUrl":"10.1016/j.jgar.2025.09.015","url":null,"abstract":"<div><h3>Objective</h3><div>Q (query) fever, caused by <em>Coxiella burnetii</em>, is often linked to negative bacterial cultures, with infective endocarditis with negative cultures difficult to diagnose and treat. Our case demonstrates that metagenomic next-generation sequencing (mNGS) is able to provide a rapid and accurate method for pathogenetic diagnosis in infectious diseases.</div></div><div><h3>Case presentation</h3><div>A case of infective endocarditis with negative blood cultures is reported in a male patient with a history of sheep farming and previous aortic valve replacement and atrial septal defect atrial septal defect repair. Blood tests showed positive serum immunofluorescent antibodies to <em>Rickettsia</em>, while mNGS of perivalvular abscess tissue suggested <em>C. burnetii</em>. Doxycycline 0.1 g q12h and hydroxychloroquine 0.2 g q12h were used for postoperative antibiotic treatment. The genome of <em>C. burnetii</em> C2245173Z was assembled on the Illumina platform and no known antibiotic resistance genes were detected. Phylogenetic analysis of the <em>C. burnetii</em> genome showed a genetic relationship between animal- and human-derived strains.</div></div><div><h3>Conclusions</h3><div>mNGS could provide a rapid and accurate assay for clinical diagnosis and play a decisive role in the pathogenetic diagnosis of some infectious diseases. Doxycycline plus hydroxychloroquine remains an effective treatment for chronic Q fever endocarditis. In addition, phylogenetic tree analysis indicates that <em>C. burnetii</em> infection may pose a potential risk to humans working with livestock.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 192-195"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient 血液透析患者罕见的肺沃林斯基分枝杆菌感染。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-09-19 DOI: 10.1016/j.jgar.2025.09.006
Lin Zheng , Yanwan Shangguan , Wanru Guo , Zhongkang Ji , Kaijin Xu
In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary Pseudomonas aeruginosa and Mycobacterium wolinskyi coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the M. wolinskyi strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of M. wolinskyi, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the M. wolinskyi strain.
近年来,非结核分枝杆菌的检出率有所提高,引起了临床的重视。在这里,我们提出一个病例肺铜绿假单胞菌和沃林斯基分枝杆菌合并感染在一个60岁的血液透析受者。据我们所知,这是首次从人类呼吸道样本中分离出沃林斯基支原体菌株,包括全面探索其对临床可用抗菌药物的敏感性。这一发现加深了我们对沃林斯基支原体感染谱的理解,强调在治疗免疫功能低下患者时需要考虑与常见病原体和不太常见的非典型病原体共感染的可能性。此外,本研究还评估了临床新开发的抗菌药物对沃林斯基支原体的体外抗菌活性。
{"title":"Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient","authors":"Lin Zheng ,&nbsp;Yanwan Shangguan ,&nbsp;Wanru Guo ,&nbsp;Zhongkang Ji ,&nbsp;Kaijin Xu","doi":"10.1016/j.jgar.2025.09.006","DOIUrl":"10.1016/j.jgar.2025.09.006","url":null,"abstract":"<div><div>In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary <em>Pseudomonas aeruginosa</em> and <em>Mycobacterium wolinskyi</em> coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the <em>M. wolinskyi</em> strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of <em>M. wolinskyi</em>, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the <em>M. wolinskyi</em> strain.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 134-137"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia 根据世卫组织认知分类,住院患者抗菌药物使用情况:沙特阿拉伯多中心点流行病学调查结果。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-09-24 DOI: 10.1016/j.jgar.2025.09.009
Nada A. Alsaleh , Abeer AlSmari , Abrar F. Alhameed , Ahmed O. Alenazi , Alaa A. Alsharif , Amal Bin Akresh , Anwar M. Alnakhli , Bashaier Alshehail , Eman A. Alzahrani , Ghadah H. Alshehri , Ghazwa B. Korayem , Hanan A. Bakri , Khalid Eljaaly , Lina I. Alnajjar , Norah S. Aldeghaither , Reem Almahasna , Sara Almuhisen , Yassmin Alsomali , Zikria Saleem

Background

Antimicrobial resistance (AMR) threatens global health by reducing the efficacy of common infection treatments. This study examines antimicrobial use in Saudi Arabian hospitals, identifies influencing factors, and proposes interventions using the World Health Organization’s (WHO) Access, Watch, Reserve (AWaRe) classification system.

Methods

A cross-sectional, multicentre point prevalence survey (PPS) of antimicrobial utilization was conducted in 10 hospitals across 6 regions of Saudi Arabia September 2023. All inpatients receiving antimicrobials on the PPS day were included. Data collection utilized the Global PPS tool developed by the University of Antwerp, Belgium.

Results

Among 2890 inpatients, 766 (26.5%) were prescribed at least one antimicrobial, resulting in a total of 982 prescriptions. The primary indications for these antimicrobials were community-acquired infections (37.1%), Healthcare-associated infections (35.9%), surgical prophylaxis (15.4%), unknown reasons (8.7%), medical prophylaxis (2.5%), and other reasons (0.3%). The most common reasons for antimicrobial use included pneumonia or lower respiratory tract infections (16.1%), skin and soft tissue infections (11%) and bacteraemia (8.9%). The most frequently prescribed antimicrobial classes were penicillins with beta-lactamase inhibitors (18.5%), carbapenems (15.7%), and third-generation cephalosporins (11.1%). Most of the antimicrobials (66.3%) were classified as Watch antimicrobials, followed by 23.8% as Access, and 8.9% as Reserve.

Conclusions

The study provides valuable insights into antimicrobial utilization in Saudi Arabia, offering a baseline for assessing prescribing patterns. While findings may reflect certain antimicrobial stewardship efforts, further investigation is needed to evaluate their impact. The study also highlights key areas for improvement, emphasizing the importance of conducting future PPS to guide antimicrobial stewardship strategies and monitor progress in managing AMR.
背景:抗菌素耐药性(AMR)通过降低常见感染治疗的有效性来威胁全球健康。本研究调查了沙特阿拉伯医院的抗菌药物使用情况,确定了影响因素,并使用世界卫生组织(WHO)的获取、观察、储备(AWaRe)分类系统提出了干预措施。方法:于2023年9月对沙特阿拉伯6个地区10家医院的抗菌药物使用情况进行横断面多中心点流行病学调查(PPS)。所有在PPS日接受抗微生物药物治疗的住院患者均被纳入。数据收集利用了比利时安特卫普大学开发的全球PPS工具。结果:2890例住院患者中,766例(26.5%)至少使用了一种抗菌药物,共使用982张处方。这些抗菌素的主要适应症为社区获得性感染(37.1%)、卫生保健相关感染(35.9%)、手术预防(15.4%)、不明原因(8.7%)、医学预防(2.5%)和其他原因(0.3%)。使用抗微生物药物的最常见原因包括肺炎或下呼吸道感染(16.1%)、皮肤和软组织感染(11%)和菌血症(8.9%)。最常用的抗菌药物是含β -内酰胺酶抑制剂的青霉素(18.5%)、碳青霉烯类(15.7%)和第三代头孢菌素(11.1%)。大多数抗菌药物(66.3%)被归类为观察类抗菌药物,其次是23.8%的可获得类抗菌药物,8.9%为储备类抗菌药物。结论:该研究为沙特阿拉伯的抗菌药物使用提供了有价值的见解,为评估处方模式提供了基线。虽然研究结果可能反映了某些抗菌药物管理工作,但需要进一步调查以评估其影响。该研究还强调了需要改进的关键领域,强调了开展未来PPS以指导抗菌素管理战略和监测抗生素耐药性管理进展的重要性。
{"title":"Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia","authors":"Nada A. Alsaleh ,&nbsp;Abeer AlSmari ,&nbsp;Abrar F. Alhameed ,&nbsp;Ahmed O. Alenazi ,&nbsp;Alaa A. Alsharif ,&nbsp;Amal Bin Akresh ,&nbsp;Anwar M. Alnakhli ,&nbsp;Bashaier Alshehail ,&nbsp;Eman A. Alzahrani ,&nbsp;Ghadah H. Alshehri ,&nbsp;Ghazwa B. Korayem ,&nbsp;Hanan A. Bakri ,&nbsp;Khalid Eljaaly ,&nbsp;Lina I. Alnajjar ,&nbsp;Norah S. Aldeghaither ,&nbsp;Reem Almahasna ,&nbsp;Sara Almuhisen ,&nbsp;Yassmin Alsomali ,&nbsp;Zikria Saleem","doi":"10.1016/j.jgar.2025.09.009","DOIUrl":"10.1016/j.jgar.2025.09.009","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) threatens global health by reducing the efficacy of common infection treatments. This study examines antimicrobial use in Saudi Arabian hospitals, identifies influencing factors, and proposes interventions using the World Health Organization’s (WHO) Access, Watch, Reserve (AWaRe) classification system.</div></div><div><h3>Methods</h3><div>A cross-sectional, multicentre point prevalence survey (PPS) of antimicrobial utilization was conducted in 10 hospitals across 6 regions of Saudi Arabia September 2023. All inpatients receiving antimicrobials on the PPS day were included. Data collection utilized the Global PPS tool developed by the University of Antwerp, Belgium.</div></div><div><h3>Results</h3><div>Among 2890 inpatients, 766 (26.5%) were prescribed at least one antimicrobial, resulting in a total of 982 prescriptions. The primary indications for these antimicrobials were community-acquired infections (37.1%), Healthcare-associated infections (35.9%), surgical prophylaxis (15.4%), unknown reasons (8.7%), medical prophylaxis (2.5%), and other reasons (0.3%). The most common reasons for antimicrobial use included pneumonia or lower respiratory tract infections (16.1%), skin and soft tissue infections (11%) and bacteraemia (8.9%). The most frequently prescribed antimicrobial classes were penicillins with beta-lactamase inhibitors (18.5%), carbapenems (15.7%), and third-generation cephalosporins (11.1%). Most of the antimicrobials (66.3%) were classified as Watch antimicrobials, followed by 23.8% as Access, and 8.9% as Reserve.</div></div><div><h3>Conclusions</h3><div>The study provides valuable insights into antimicrobial utilization in Saudi Arabia, offering a baseline for assessing prescribing patterns. While findings may reflect certain antimicrobial stewardship efforts, further investigation is needed to evaluate their impact. The study also highlights key areas for improvement, emphasizing the importance of conducting future PPS to guide antimicrobial stewardship strategies and monitor progress in managing AMR.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 147-156"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145176153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of ST23-K1 blaKPC-3-positive hypervirulent carbapenem-resistant Klebsiella pneumoniae from China: A molecular, biological, and epidemiological study 来自中国的ST23-K1 blakpc -3阳性高毒力耐碳青霉烯肺炎克雷伯菌的出现:分子、生物学和流行病学研究
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-10-10 DOI: 10.1016/j.jgar.2025.09.007
Ling Xin, Jing Wang, Cong Qin, Yi Sun, Hongwei Zhou, Rong Zhang, Gongxiang Chen

Objective

A highly virulent Klebsiella pneumoniae ST23-K1 carrying blaKPC-3, named as Kpn_24-5, was identified in the blood samples of a patient with multiple complications. We investigated the transfer and pathogenic mechanism of this strain, and elucidated the epidemiological situation of the strain.

Methods

A blaKPC-3-positive ST23-K1 K. pneumoniae was isolated. Antimicrobial susceptibility test and whole genome sequencing were used to study the phenotypes and genotypes of the strain. The transmission and pathogenic mechanism were investigated by means of conjugation transfer test, neutrophil killing test, and serum inhibition test.

Results

The Kpn_24-5 strain was ST23 sequence type and K64:O1 capsular serotype, which contains four plasmids. Plasmid 1 carries several virulence genes, belonging to the same clade as K. pneumoniae plasmid isolated from the USA in 2023. Plasmid 2 is an anti-plasmid containing blaKPC-3 carbapenem resistance gene, belonging to the same clade as K. pneumoniae plasmid isolated from China in 2024. The genetic characteristics of plasmids indicated that the genetic environment of blaKPC-3 in plasmid 2 of Kpn_24-5 strain was IS26-ISKpn27-blaKPC-3-Tn21. The resistance plasmid 2 of Kpn_24-5 strain was transferable. The Kpn_24-5 strain has higher tolerance to neutrophils, is not easily inhibited by serum, and has significantly higher infectivity.

Conclusions

The present study corroborates the emergence of hypervirulent CR-hvKP in the Zhejiang region, a phenomenon that is presumably attributable to the acquisition of an IncFIB virulence plasmid and a blaKPC-3 resistance plasmid by the ST23-K1 type K. pneumoniae. Our findings highlight the urgent need to use antibiotics more wisely to limit the emergence of resistance.
目的:在一例多发性并发症患者的血液样本中发现一株携带blaKPC-3的高毒力肺炎克雷伯菌ST23-K1,命名为Kpn_24-5。研究了该菌株的转移和致病机制,并阐明了该菌株的流行病学情况。方法:分离一株blakpc -3阳性的ST23-K1肺炎克雷伯菌。采用药敏试验和全基因组测序对该菌株进行表型和基因型研究。通过偶联转移试验、嗜中性粒细胞杀伤试验和血清抑制试验,探讨其传播和致病机制。结果:Kpn_24-5菌株为ST23血清型,含K1胶囊,包含4个质粒。质粒1携带多个毒力基因,与2023年从美国分离的肺炎克雷伯菌质粒属于同一进化支。质粒2为含有blaKPC-3碳青霉烯类耐药基因的抗质粒,与2024年从中国分离到的肺炎克雷伯菌质粒属同一支。质粒遗传特征表明,菌株Kpn_24-5质粒2中blaKPC-3的遗传环境为IS26-ISKpn27-blaKPC-3-Tn21。Kpn_24-5菌株的抗性质粒2具有可转移性。Kpn_24-5菌株对中性粒细胞有较高的耐受性,不易被血清抑制,具有明显较高的传染性。结论:本研究证实了高毒力CR-hvKP在浙江地区的出现,这一现象可能是由于ST23-K1型肺炎克雷伯菌获得了IncFIB毒力质粒和blaKPC-3抗性质粒。我们的发现强调了迫切需要更明智地使用抗生素来限制耐药性的出现。
{"title":"Emergence of ST23-K1 blaKPC-3-positive hypervirulent carbapenem-resistant Klebsiella pneumoniae from China: A molecular, biological, and epidemiological study","authors":"Ling Xin,&nbsp;Jing Wang,&nbsp;Cong Qin,&nbsp;Yi Sun,&nbsp;Hongwei Zhou,&nbsp;Rong Zhang,&nbsp;Gongxiang Chen","doi":"10.1016/j.jgar.2025.09.007","DOIUrl":"10.1016/j.jgar.2025.09.007","url":null,"abstract":"<div><h3>Objective</h3><div>A highly virulent <em>Klebsiella pneumoniae</em> ST23-K1 carrying <em>bla</em><sub>KPC-3</sub>, named as Kpn_24-5, was identified in the blood samples of a patient with multiple complications. We investigated the transfer and pathogenic mechanism of this strain, and elucidated the epidemiological situation of the strain.</div></div><div><h3>Methods</h3><div>A <em>bla</em><sub>KPC-3-</sub>positive ST23-K1 <em>K. pneumoniae</em> was isolated. Antimicrobial susceptibility test and whole genome sequencing were used to study the phenotypes and genotypes of the strain. The transmission and pathogenic mechanism were investigated by means of conjugation transfer test, neutrophil killing test, and serum inhibition test.</div></div><div><h3>Results</h3><div>The Kpn_24-5 strain was ST23 sequence type and K64:O1 capsular serotype, which contains four plasmids. Plasmid 1 carries several virulence genes, belonging to the same clade as <em>K. pneumoniae</em> plasmid isolated from the USA in 2023. Plasmid 2 is an anti-plasmid containing <em>bla</em><sub>KPC-3</sub> carbapenem resistance gene, belonging to the same clade as <em>K. pneumoniae</em> plasmid isolated from China in 2024. The genetic characteristics of plasmids indicated that the genetic environment of <em>bla</em><sub>KPC-3</sub> in plasmid 2 of Kpn_24-5 strain was IS26-ISKpn27-<em>bla</em><sub>KPC-3</sub>-Tn21. The resistance plasmid 2 of Kpn_24-5 strain was transferable. The Kpn_24-5 strain has higher tolerance to neutrophils, is not easily inhibited by serum, and has significantly higher infectivity.</div></div><div><h3>Conclusions</h3><div>The present study corroborates the emergence of hypervirulent CR-hvKP in the Zhejiang region, a phenomenon that is presumably attributable to the acquisition of an IncFIB virulence plasmid and a <em>bla</em><sub>KPC-3</sub> resistance plasmid by the ST23-K1 type <em>K. pneumoniae</em>. Our findings highlight the urgent need to use antibiotics more wisely to limit the emergence of resistance.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 234-239"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
blaNDM-5 is the predominant variant of blaNDM gene in Klebsiella species detected in Mississippi, USA blaNDM-5是在美国密西西比州克雷伯菌中检测到的blaNDM基因的显性变异。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-10-21 DOI: 10.1016/j.jgar.2025.10.014
Srimadhav Nallani , Saihou Ceesay , Abiye Iyo, Lucersia Nichols, Daphne Ware, Beata Karolewicz

Objectives

The Mississippi Public Health Laboratory conducts active surveillance of carbapenem-resistant Enterobacterales (CRE) infections as part of the Antimicrobial Resistance Laboratory Network (ARLN) program implemented by the United States Centers for Disease Control and Prevention (CDC). Here, we describe the prevalence of New Delhi Metallo-β-lactamase (blaNDM) genes in Klebsiella, a major pathogen of the Enterobacterales order linked to nosocomial infections, between January 2022 and June 2025.

Methods

Carbapenemase activity was confirmed using the Modified Carbapenem Inactivation Method (mCIM). PCR was then performed on carbapenemase-positive isolates to detect blaNDM genes. Whole-genome sequencing (WGS) was performed on 35 blaNDM-positive isolates to identify blaNDM gene variants, other antimicrobial resistance (AMR) determinants, virulence factors, and plasmids. Antibiotic susceptibility testing (AST) was determined by the Kirby-Bauer disk diffusion assay.

Results

Among the 35 NDM-positive Klebsiella species, the blaNDM-5 variant was identified in 23 (65.7%) isolates, followed by blaNDM-1 and blaNDM-7 genes which were identified in 6/35 (17%) and 6/35 (17%) cases, respectively. A significant proportion of blaNDM-5 cases also harbored additional β-lactamase genes such as blaSHV family (18/23; 78%) and blaTEM-1 (9/23; 39%) indicating multi-drug resistance. All 23 blaNDM-5-positive isolates were resistant to carbapenems and broad-spectrum cephalosporins, but 13/23 (56.5%) remained susceptible to aztreonam. PlasmidFinder analysis identified IncX3 (20/23) and IncFIB(K) (19/23) as the predominant plasmid replicons among these isolates.

Conclusion

The emergence and spread of bacteria carrying blaNDM-5 gene poses a significant threat to public health in Mississippi. Our dataset warrants further study to investigate the potential role of plasmids in blaNDM-5 dissemination.
目的:密西西比公共卫生实验室对碳青霉烯耐药肠杆菌(CRE)感染进行积极监测,作为美国疾病控制和预防中心(CDC)实施的抗菌素耐药性实验室网络(ARLN)计划的一部分。在这里,我们描述了2022年1月至2025年6月期间克雷伯氏菌中新德里金属β-内酰胺酶(blaNDM)基因的流行情况,克雷伯氏菌是与医院感染相关的肠杆菌目的主要病原体。方法:采用改良碳青霉烯酶失活法(mCIM)测定碳青霉烯酶活性。然后对碳青霉烯酶阳性分离株进行PCR检测blaNDM基因。对35株blaNDM阳性分离株进行全基因组测序(WGS),以鉴定blaNDM基因变异、其他抗微生物药物耐药性(AMR)决定因素、毒力因子和质粒。采用Kirby-Bauer纸片扩散法进行药敏试验(AST)。结果:35株ndm阳性克雷伯菌中,检出blaNDM-5基因的有23株(65.7%),检出blaNDM-1基因的有6/35(17%),检出blaNDM-7基因的有6/35(17%)。相当比例的blaNDM-5病例还携带额外的β-内酰胺酶基因,如blaSHV家族(18/23;78%)和blandm -1(9/23; 39%),表明多药耐药。23株blandm -5阳性菌株均对碳青霉烯类和广谱头孢菌素耐药,13/23株(56.5%)对氨曲南敏感。PlasmidFinder分析发现IncX3(20/23)和IncFIB(K)(19/23)是这些分离株中主要的质粒复制子。结论:携带blaNDM-5基因的细菌的出现和传播对密西西比州的公共卫生构成了重大威胁。我们的数据集值得进一步研究,以调查质粒在blaNDM-5传播中的潜在作用。
{"title":"blaNDM-5 is the predominant variant of blaNDM gene in Klebsiella species detected in Mississippi, USA","authors":"Srimadhav Nallani ,&nbsp;Saihou Ceesay ,&nbsp;Abiye Iyo,&nbsp;Lucersia Nichols,&nbsp;Daphne Ware,&nbsp;Beata Karolewicz","doi":"10.1016/j.jgar.2025.10.014","DOIUrl":"10.1016/j.jgar.2025.10.014","url":null,"abstract":"<div><h3>Objectives</h3><div>The Mississippi Public Health Laboratory conducts active surveillance of carbapenem-resistant <em>Enterobacterales</em> (CRE) infections as part of the Antimicrobial Resistance Laboratory Network (ARLN) program implemented by the United States Centers for Disease Control and Prevention (CDC). Here, we describe the prevalence of New Delhi Metallo-β-lactamase (<em>bla</em><sub>NDM</sub>) genes in <em>Klebsiella</em>, a major pathogen of the <em>Enterobacterales</em> order linked to nosocomial infections, between January 2022 and June 2025.</div></div><div><h3>Methods</h3><div>Carbapenemase activity was confirmed using the Modified Carbapenem Inactivation Method (mCIM). PCR was then performed on carbapenemase-positive isolates to detect <em>bla</em><sub>NDM</sub> genes. Whole-genome sequencing (WGS) was performed on 35 <em>bla</em><sub>NDM</sub>-positive isolates to identify <em>bla</em><sub>NDM</sub> gene variants, other antimicrobial resistance (AMR) determinants, virulence factors, and plasmids. Antibiotic susceptibility testing (AST) was determined by the Kirby-Bauer disk diffusion assay.</div></div><div><h3>Results</h3><div>Among the 35 NDM-positive <em>Klebsiella</em> species, the <em>bla</em><sub>NDM-5</sub> variant was identified in 23 (65.7%) isolates, followed by <em>bla</em><sub>NDM-1</sub> and <em>bla</em><sub>NDM-7</sub> genes which were identified in 6/35 (17%) and 6/35 (17%) cases, respectively. A significant proportion of <em>bla</em><sub>NDM-5</sub> cases also harbored additional β-lactamase genes such as <em>bla</em><sub>SHV</sub> family (18/23; 78%) and <em>bla</em><sub>TEM-1</sub> (9/23; 39%) indicating multi-drug resistance. All 23 <em>bla</em><sub>NDM-5</sub>-positive isolates were resistant to carbapenems and broad-spectrum cephalosporins, but 13/23 (56.5%) remained susceptible to aztreonam. PlasmidFinder analysis identified IncX3 (20/23) and IncFIB(K) (19/23) as the predominant plasmid replicons among these isolates.</div></div><div><h3>Conclusion</h3><div>The emergence and spread of bacteria carrying <em>bla</em><sub>NDM-5</sub> gene poses a significant threat to public health in Mississippi. Our dataset warrants further study to investigate the potential role of plasmids in <em>bla</em><sub>NDM-5</sub> dissemination.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 282-286"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145354938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serotypes and antimicrobial resistance patterns of food-borne Salmonella isolates in the Jiaxing Region, China, from 2020 to 2024 2020 - 2024年嘉兴地区食源性沙门氏菌分离株血清型及耐药性分析
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-10-27 DOI: 10.1016/j.jgar.2025.10.023
Xiaoqin Niu , Liping Tu , Qinlong Yu , Binbin Lu , Junhua Tian , Wei Wang , Bailong Hou , Weifeng Shen

Background

Salmonella is a worldwide food-borne pathogen, which brings significant challenges to clinical practice due to the increase of antibiotic resistance.

Objective

This study aims to explore the serotype variety and antibiotic resistance of food-borne Salmonella in the Jiaxing region from 2020 to 2024.

Methods

The faecal samples of 8541 patients with food-borne diseases were investigated. The isolated Salmonella strains underwent MALDI-TOF, serological typing, and drug susceptibility testing.

Results

A total of 622 Salmonella strains were isolated from 8541 faecal samples, with 382 (61.4%) originating from patients under 6 y old. Summer and autumn were the peak seasons. 622 strains of Salmonella were divided into 53 serotypes, with the most common serotypes being Salmonella Typhimurium and Salmonella Enteritidis. The drug susceptibility test revealed that most strains were resistant to ampicillin (79.8%), while 38% exhibited resistance to trimethoprim/sulfamethoxazole. The susceptibility rate to cephalosporins and fluoroquinolones was over 84%. Only one strain was found to be resistant to carbapenems. Notably, 69.5% of the strains were resistant to at least one antibiotic, and 21.9% demonstrated multidrug resistance. Our findings also indicated an increasing trend in the resistance of isolated strains to ceftriaxone and cefepime over the past 5 y. Compared to S. Typhimurium, S. Enteritidis was more susceptible to a range of antibiotics, with the most notable difference in susceptibility to trimethoprim/sulfamethoxazole.

Conclusions

Salmonella serotypes exhibited varied patterns of drug susceptibility. Antibiotic selection should be based on the susceptibility profile of the pathogenic bacteria to effectively treat and prevent Salmonella infections.
背景:沙门氏菌是一种世界性的食源性致病菌,由于抗生素耐药性的增加,给临床实践带来了重大挑战。目的:了解2020 - 2024年嘉兴地区食源性沙门氏菌的血清型、品种及耐药性。方法:对8541例食源性疾病患者粪便标本进行调查。对分离的沙门氏菌进行MALDI-TOF、血清学分型和药敏试验。结果:从8541份粪便中分离出622株沙门氏菌,其中382株(61.4%)来自6岁以下患者。夏季和秋季是高峰期。622株沙门菌分为53种血清型,以鼠伤寒沙门菌和肠炎沙门菌最为常见。药敏试验结果显示,大多数菌株对氨苄西林耐药(79.8%),对甲氧苄啶/磺胺甲恶唑耐药(38%)。头孢菌素类和氟喹诺酮类药物的易感率均在84%以上。只有一种菌株被发现对碳青霉烯类具有耐药性。值得注意的是,69.5%的菌株至少对一种抗生素耐药,21.9%的菌株表现出多药耐药。我们的研究结果还表明,在过去的五年中,分离菌株对头孢曲松和头孢吡肟的耐药性呈上升趋势。与鼠伤寒沙门氏菌相比,肠炎沙门氏菌对一系列抗生素更敏感,其中对甲氧苄啶/磺胺甲恶唑的敏感性差异最显著。结论:沙门氏菌血清型具有不同的药敏模式。应根据病原菌的药敏特征选择抗生素,以有效治疗和预防沙门氏菌感染。
{"title":"Serotypes and antimicrobial resistance patterns of food-borne Salmonella isolates in the Jiaxing Region, China, from 2020 to 2024","authors":"Xiaoqin Niu ,&nbsp;Liping Tu ,&nbsp;Qinlong Yu ,&nbsp;Binbin Lu ,&nbsp;Junhua Tian ,&nbsp;Wei Wang ,&nbsp;Bailong Hou ,&nbsp;Weifeng Shen","doi":"10.1016/j.jgar.2025.10.023","DOIUrl":"10.1016/j.jgar.2025.10.023","url":null,"abstract":"<div><h3>Background</h3><div><em>Salmonella</em> is a worldwide food-borne pathogen, which brings significant challenges to clinical practice due to the increase of antibiotic resistance.</div></div><div><h3>Objective</h3><div>This study aims to explore the serotype variety and antibiotic resistance of food-borne <em>Salmonella</em> in the Jiaxing region from 2020 to 2024.</div></div><div><h3>Methods</h3><div>The faecal samples of 8541 patients with food-borne diseases were investigated. The isolated <em>Salmonella</em> strains underwent MALDI-TOF, serological typing, and drug susceptibility testing.</div></div><div><h3>Results</h3><div>A total of 622 <em>Salmonella</em> strains were isolated from 8541 faecal samples, with 382 (61.4%) originating from patients under 6 y old. Summer and autumn were the peak seasons. 622 strains of <em>Salmonella</em> were divided into 53 serotypes, with the most common serotypes being <em>Salmonella</em> Typhimurium and <em>Salmonella</em> Enteritidis. The drug susceptibility test revealed that most strains were resistant to ampicillin (79.8%), while 38% exhibited resistance to trimethoprim/sulfamethoxazole. The susceptibility rate to cephalosporins and fluoroquinolones was over 84%. Only one strain was found to be resistant to carbapenems. Notably, 69.5% of the strains were resistant to at least one antibiotic, and 21.9% demonstrated multidrug resistance. Our findings also indicated an increasing trend in the resistance of isolated strains to ceftriaxone and cefepime over the past 5 y. Compared to <em>S</em>. Typhimurium, <em>S</em>. Enteritidis was more susceptible to a range of antibiotics, with the most notable difference in susceptibility to trimethoprim/sulfamethoxazole.</div></div><div><h3>Conclusions</h3><div><em>Salmonella</em> serotypes exhibited varied patterns of drug susceptibility. Antibiotic selection should be based on the susceptibility profile of the pathogenic bacteria to effectively treat and prevent <em>Salmonella</em> infections.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 294-298"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145401066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards an interpretable machine learning model for predicting antimicrobial resistance 迈向预测抗菌素耐药性的可解释机器学习模型。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-08-25 DOI: 10.1016/j.jgar.2025.08.011
Mohamed Mediouni, Vladimir Makarenkov, Abdoulaye Baniré Diallo
This article explores the main stages of developing an interpretable machine learning (ML) model for predicting antimicrobial resistance (AMR), highlighting the importance of model interpretability in enhancing the prediction performance. By integrating phenotype-genotype synergy, our goal is to better understand AMR mechanisms. Such an approach combines ML with biological insights, offering a pathway towards more reliable AMR predictions and advancing the discovery of effective treatments against resistant pathogens. The challenges and opportunities related to incorporating this synergy into an ML model are discussed.
本文探讨了开发用于预测抗菌素耐药性(AMR)的可解释机器学习(ML)模型的主要阶段,强调了模型可解释性在提高预测性能方面的重要性。通过整合表型-基因型协同作用,我们的目标是更好地了解抗菌素耐药性机制。这种方法将机器学习与生物学见解相结合,为更可靠的AMR预测提供了一条途径,并推动了对耐药病原体的有效治疗的发现。讨论了将这种协同作用纳入ML模型的挑战和机遇。
{"title":"Towards an interpretable machine learning model for predicting antimicrobial resistance","authors":"Mohamed Mediouni,&nbsp;Vladimir Makarenkov,&nbsp;Abdoulaye Baniré Diallo","doi":"10.1016/j.jgar.2025.08.011","DOIUrl":"10.1016/j.jgar.2025.08.011","url":null,"abstract":"<div><div>This article explores the main stages of developing an interpretable machine learning (ML) model for predicting antimicrobial resistance (AMR), highlighting the importance of model interpretability in enhancing the prediction performance. By integrating phenotype-genotype synergy, our goal is to better understand AMR mechanisms. Such an approach combines ML with biological insights, offering a pathway towards more reliable AMR predictions and advancing the discovery of effective treatments against resistant pathogens. The challenges and opportunities related to incorporating this synergy into an ML model are discussed.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 47-51"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144956924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between pneumococcal serotypes and antimicrobial resistance: A systematic review and meta-analysis 肺炎球菌血清型与抗菌药物耐药性的关系:一项系统综述和荟萃分析。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-07-14 DOI: 10.1016/j.jgar.2025.07.008
Onyansaniba K. Ntim , Aaron Awere-Duodu , Samuel Addo Akwetey , Fleischer C.N. Kotey , Eric S. Donkor

Background

The diversity of pneumococcal serotypes poses significant challenges for both vaccination and treatment. Clinical management of pneumococcal infections is further complicated by the fact that individual serotypes exhibit distinct antimicrobial resistance patterns. This study aims to comprehensively estimate the antimicrobial resistance rates of pneumococcal serotypes.

Methods

A comprehensive search was conducted in PubMed, Scopus, Web of Science, and ScienceDirect. A random-effect meta-analysis was used to pool the number of isolates resistant to a particular antimicrobial per total number of isolates tested for each pneumococcal serotype.

Results

Ninety studies were included in the analysis. The study identified 66 pneumococcal serotypes, with vaccine serotypes such as 19A, 19F, 23F, 6B, 14, 6A, 3, and 9V being the most frequently reported. Non-vaccine serotypes like 15A, 6C, 23A, 23B, 15B, and 35B were also prevalent. Most serotypes were associated with pneumococcal diseases. Serotypes exhibited varying and high resistance to cefuroxime, co-trimoxazole, tetracycline, macrolides, and clindamycin. The highest multidrug resistance was observed in serotypes 23F (63.34%, 95% CI [25.77; 94.31]), 15C (61.04%, 95% CI [0.74; 100.00]), 23A (57.28%, 95% CI [27.60; 84.58]), 19F (55.95%, 95% CI [30.26; 80.22]), 19A (54.07%, 95% CI [32.60; 74.90]), 15B (47.10%, 95% CI [9.66; 86.41]), 24F (45.77%, 95% CI [3.79; 91.31]), 15A (44.28%, 95% CI [29.58; 59.26]), and 6B (43.79%, 95% CI [28.48; 59.12]).

Conclusions

This study highlights significant antimicrobial resistance among both vaccine (19A, 19F, 23F, 14, 6A, and 6B) and non-vaccine types (15A, 6C, 23A, 20, 15C, and 35B). Our findings emphasize the need for effective surveillance and targeted interventions to fight these resistant pneumococcal serotypes.
背景:肺炎球菌的多种血清型使疫苗接种和治疗具有挑战性。治疗并发症是不同血清型表现出不同耐药率的结果。本研究旨在综合估计肺炎球菌血清型的抗菌素耐药率。方法:综合检索PubMed、Scopus、Web of Science、ScienceDirect。随机效应荟萃分析用于汇总每种肺炎球菌血清型检测的分离株总数中对特定抗菌素耐药的分离株数量。结果:90项研究被纳入分析。该研究确定了66种肺炎球菌血清型,其中最常报告的疫苗血清型包括19A、19F、23F、6B、14、6A、3和9V。非疫苗血清型如15A、6C、23A、23B、15B和35B也很普遍。大多数血清型与肺炎球菌疾病相关。血清型对头孢呋辛、复方新诺明、四环素、大环内酯类和克林霉素表现出不同程度的高耐药性。血清型23F为多药耐药最高(63.34%,95% CI [25.77;94.31]), 15c (61.04%, 95% ci [0.74;100.00]), 23a (57.28%, 95% ci [27.60;[84.58]), 19f (55.95%, 95% ci [30.26;80.22]), 19a (54.07%, 95% ci [32.60;74.90]), 15b (47.10%, 95% ci [9.66;86.41]), 24f (45.77%, 95% ci [3.79;91.31]), 15a (44.28%, 95% ci [29.58;59.26]), 6B (43.79%, 95% CI [28.48;59.12])。结论:本研究强调疫苗(19A、19F、23F、14、6A和6B)和非疫苗类型(15A、6C、23A、20、15C和35B)均存在显著的抗微生物药物耐药性。我们的研究结果强调需要有效的监测和有针对性的干预措施来对抗这些耐药肺炎球菌血清型。
{"title":"Relationship between pneumococcal serotypes and antimicrobial resistance: A systematic review and meta-analysis","authors":"Onyansaniba K. Ntim ,&nbsp;Aaron Awere-Duodu ,&nbsp;Samuel Addo Akwetey ,&nbsp;Fleischer C.N. Kotey ,&nbsp;Eric S. Donkor","doi":"10.1016/j.jgar.2025.07.008","DOIUrl":"10.1016/j.jgar.2025.07.008","url":null,"abstract":"<div><h3>Background</h3><div>The diversity of pneumococcal serotypes poses significant challenges for both vaccination and treatment. Clinical management of pneumococcal infections is further complicated by the fact that individual serotypes exhibit distinct antimicrobial resistance patterns. This study aims to comprehensively estimate the antimicrobial resistance rates of pneumococcal serotypes.</div></div><div><h3>Methods</h3><div>A comprehensive search was conducted in PubMed, Scopus, Web of Science, and ScienceDirect. A random-effect meta-analysis was used to pool the number of isolates resistant to a particular antimicrobial per total number of isolates tested for each pneumococcal serotype.</div></div><div><h3>Results</h3><div>Ninety studies were included in the analysis. The study identified 66 pneumococcal serotypes, with vaccine serotypes such as 19A, 19F, 23F, 6B, 14, 6A, 3, and 9V being the most frequently reported. Non-vaccine serotypes like 15A, 6C, 23A, 23B, 15B, and 35B were also prevalent. Most serotypes were associated with pneumococcal diseases. Serotypes exhibited varying and high resistance to cefuroxime, co-trimoxazole, tetracycline, macrolides, and clindamycin. The highest multidrug resistance was observed in serotypes 23F (63.34%, 95% CI [25.77; 94.31]), 15C (61.04%, 95% CI [0.74; 100.00]), 23A (57.28%, 95% CI [27.60; 84.58]), 19F (55.95%, 95% CI [30.26; 80.22]), 19A (54.07%, 95% CI [32.60; 74.90]), 15B (47.10%, 95% CI [9.66; 86.41]), 24F (45.77%, 95% CI [3.79; 91.31]), 15A (44.28%, 95% CI [29.58; 59.26]), and 6B (43.79%, 95% CI [28.48; 59.12]).</div></div><div><h3>Conclusions</h3><div>This study highlights significant antimicrobial resistance among both vaccine (19A, 19F, 23F, 14, 6A, and 6B) and non-vaccine types (15A, 6C, 23A, 20, 15C, and 35B). Our findings emphasize the need for effective surveillance and targeted interventions to fight these resistant pneumococcal serotypes.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 52-67"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144649661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal carriage of staphylococcus aureus in rural China: Molecular epidemiology and antimicrobial susceptibility 中国农村金黄色葡萄球菌鼻腔携带:分子流行病学和抗菌药物敏感性。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-08-13 DOI: 10.1016/j.jgar.2025.08.004
Lu Liu , Shuang Wang , Yanru Chen , Xinyu Xian , Xiaolin Yu , Yan Li , Yuzhen Chen , Gaoxiang Sun , Lixiao Cheng , Ti Liu , Zengqiang Kou

Objectives

This study investigated the prevalence of nasal carriage, molecular characteristics, antimicrobial resistance (AMR) patterns, and phylogenetic relationships of Staphylococcus aureus among healthy individuals in rural communities in China.

Methods

Nasal swabs were obtained from 646 asymptomatic residents across 10 villages. All S. aureus isolates underwent antimicrobial susceptibility testing and whole-genome sequencing. Comprehensive genomic analyses were performed to predict antibiotic resistance genes and to determine multilocus sequence typing (MLST), spa types, and Staphylococcal Cassette Chromosome mec (SCCmec) classifications, along with other molecular features. Phylogenetic relationships were inferred using single-nucleotide polymorphism (SNP)-based analysis.

Results

From 646 nasal swabs collected from healthy individuals in rural communities, 48 S. aureus isolates were recovered. Among these, 16.67% (8/48) isolates were identified as methicillin-resistant S. aureus (MRSA), resulting in an overall MRSA carriage rate of 1.24% (8/646); 75% (36/48) of the isolates were identified as multidrug-resistant, and the resistance rates to penicillin and erythromycin were relatively high, at 95.83% (46/48) and 91.67% (44/48) respectively. In total, 23 spa types and 12 MLSTs were identified, with t34, ST398, and ST59 being the most prevalent. Dominant MRSA clones included ST59-t437-IVa and ST9-t899-XII. Phylogenetic analysis revealed close genetic relatedness between local isolates and strains of porcine origin or those previously reported in Germany, indicating potential interspecies and transboundary transmission pathways.

Conclusion

The findings highlighted a concerning S. aureus AMR burden among healthy rural populations in China and provided molecular evidence supporting the existence of animal-environment-human transmission routes. These results underscored critical gaps in current One Health frameworks and called for urgent, integrated interventions to mitigate the complex and interconnected nature of AMR threats.
目的:研究中国农村健康人群中金黄色葡萄球菌的鼻腔携带流行情况、分子特征、耐药性(AMR)模式和系统发育关系。方法:对10个村646名无症状居民进行鼻拭子采集。所有金黄色葡萄球菌分离株均进行了抗菌药敏试验和全基因组测序。进行了全面的基因组分析,以预测抗生素耐药基因,确定多位点序列分型(MLST)、spa型和葡萄球菌盒染色体mec (SCCmec)分类,以及其他分子特征。系统发育关系通过基于单核苷酸多态性(SNP)的分析推断。结果:从农村健康人群采集的646份鼻拭子中检出48株金黄色葡萄球菌。其中,16.67%(8/48)分离株被鉴定为耐甲氧西林金黄色葡萄球菌(MRSA),总体MRSA携带率为1.24% (8/646);75%(36/48)的分离菌被鉴定为多重耐药,对青霉素和红霉素的耐药率较高,分别为95.83%(46/48)和91.67%(44/48)。共鉴定出23种spa类型和12种mlst,其中以t34、ST398和ST59最为常见。优势MRSA克隆包括ST59-t437-IVa和ST9-t899-XII。系统发育分析显示,当地分离株与猪源株或先前在德国报告的菌株之间具有密切的遗传亲缘关系,表明可能存在种间和跨界传播途径。结论:研究结果强调了金黄色葡萄球菌AMR在中国农村健康人群中的负担,并提供了支持存在动物-环境-人类传播途径的分子证据。这些结果突出了当前“同一个健康”框架的重大差距,并呼吁采取紧急综合干预措施,以减轻抗菌素耐药性威胁的复杂性和相互关联性。
{"title":"Nasal carriage of staphylococcus aureus in rural China: Molecular epidemiology and antimicrobial susceptibility","authors":"Lu Liu ,&nbsp;Shuang Wang ,&nbsp;Yanru Chen ,&nbsp;Xinyu Xian ,&nbsp;Xiaolin Yu ,&nbsp;Yan Li ,&nbsp;Yuzhen Chen ,&nbsp;Gaoxiang Sun ,&nbsp;Lixiao Cheng ,&nbsp;Ti Liu ,&nbsp;Zengqiang Kou","doi":"10.1016/j.jgar.2025.08.004","DOIUrl":"10.1016/j.jgar.2025.08.004","url":null,"abstract":"<div><h3>Objectives</h3><div>This study investigated the prevalence of nasal carriage, molecular characteristics, antimicrobial resistance (AMR) patterns, and phylogenetic relationships of <em>Staphylococcus aureus</em> among healthy individuals in rural communities in China.</div></div><div><h3>Methods</h3><div>Nasal swabs were obtained from 646 asymptomatic residents across 10 villages. All <em>S. aureus</em> isolates underwent antimicrobial susceptibility testing and whole-genome sequencing. Comprehensive genomic analyses were performed to predict antibiotic resistance genes and to determine multilocus sequence typing (MLST), <em>spa</em> types, and <em>Staphylococcal Cassette Chromosome mec</em> (SCCmec) classifications, along with other molecular features. Phylogenetic relationships were inferred using single-nucleotide polymorphism (SNP)-based analysis.</div></div><div><h3>Results</h3><div>From 646 nasal swabs collected from healthy individuals in rural communities, 48 <em>S. aureus</em> isolates were recovered. Among these, 16.67% (8/48) isolates were identified as methicillin-resistant <em>S. aureus</em> (MRSA), resulting in an overall MRSA carriage rate of 1.24% (8/646); 75% (36/48) of the isolates were identified as multidrug-resistant, and the resistance rates to penicillin and erythromycin were relatively high, at 95.83% (46/48) and 91.67% (44/48) respectively. In total, 23 <em>spa</em> types and 12 MLSTs were identified, with t34, ST398, and ST59 being the most prevalent. Dominant MRSA clones included ST59-t437-IVa and ST9-t899-XII. Phylogenetic analysis revealed close genetic relatedness between local isolates and strains of porcine origin or those previously reported in Germany, indicating potential interspecies and transboundary transmission pathways.</div></div><div><h3>Conclusion</h3><div>The findings highlighted a concerning <em>S. aureus</em> AMR burden among healthy rural populations in China and provided molecular evidence supporting the existence of animal-environment-human transmission routes. These results underscored critical gaps in current One Health frameworks and called for urgent, integrated interventions to mitigate the complex and interconnected nature of AMR threats.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 41-46"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular characterization of blaVIM-2-carrying Pseudomonas asiatica L2126: identification of a ∼44 kb untypable plasmid with intra-genus dissemination potential 携带blavim -2的亚洲假单胞菌L2126的分子特性:鉴定一个具有属内传播潜力的~ 44 kb不可分质粒。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-12-01 Epub Date: 2025-09-27 DOI: 10.1016/j.jgar.2025.09.012
Jinhua Zhang , Yi Liu , Lei Fang , Xinrui Wang , Hao Xu , Danfeng Lou

Objectives

This study aims to elucidate the molecular characteristics of a blaVIM-2-carrying Pseudomonas asiatica isolate (L2126) from China and to characterize a ∼44 kb untypable plasmid harboring blaVIM-2. We investigated the genetic context of blaVIM-2, assessed the associated antimicrobial resistance determinants, and explored the role of this plasmid in mediating gene dissemination.

Methods

The isolate L2126 was recovered from an intestinal colonization sample in a patient from Hangzhou, China. Species identification was confirmed by average nucleotide identity (ANI) analysis. Hybrid whole-genome sequencing was performed using Illumina short-read and Oxford Nanopore long-read platforms. Genome assembly was conducted using Unicycler and annotated with Prokka. Antimicrobial resistance genes were identified via ResFinder and CARD. The genetic context of blaVIM-2 was delineated using IntegronFinder. Plasmid profiles were determined by S1-nuclease pulsed-field gel electrophoresis (S1-PFGE) and in silico replicon analysis.

Results

L2126 exhibited a multidrug-resistant profile with high-level resistance to carbapenems, cephalosporins, and fluoroquinolones. Genome analysis revealed 7 resistance genes, including blaVIM-2 and sul1. Notably, blaVIM-2 resides within a class 1 integron (intI1-attI1-blaVIM-2-qacEΔ1-sul1) embedded in a Tn402-like platform on a ∼44 kb untypable plasmid. The adjacent tni module (tniR-tniQ-tniB-tniA) is encoded on the opposite strand, indicating that it is part of the transposition platform rather than the integron cassette array. S1-PFGE confirmed the presence of the ∼44 kb plasmid, and in silico analysis provided a schematic representation of its genetic organization. BLAST analysis demonstrated that this plasmid shares high sequence homology with a plasmid previously identified in Pseudomonas monteilii, despite the two isolates belonging to different species.

Conclusions

Our findings demonstrate that the carriage of blaVIM-2 on a novel ∼44 kb untypable plasmid in P. asiatica L2126 could facilitate horizontal gene transfer of carbapenem resistance. The plasmid’s high homology to one previously identified in P. monteilii suggests that it has the potential for intra-genus dissemination, posing a significant threat to the spread of carbapenem resistance.
目的:本研究旨在阐明来自中国的携带blaVIM-2的亚洲假单胞菌分离物(L2126)的分子特征,并对携带blaVIM-2的约44 kb不可分质粒进行表征。我们研究了blaVIM-2的遗传背景,评估了相关的抗菌素耐药性决定因素,并探讨了该质粒在介导基因传播中的作用。方法:从中国杭州1例患者的肠道定植样本中分离得到L2126。物种鉴定采用平均核苷酸同源性(ANI)分析。使用Illumina short-read和Oxford Nanopore long-read平台进行杂交全基因组测序。用Unicycler进行基因组组装,并用Prokka进行注释。通过ResFinder和CARD鉴定耐药基因。使用IntegronFinder描述blaVIM-2的遗传背景。质粒谱由s1 -核酸酶脉冲场凝胶电泳(S1-PFGE)和硅复制子分析确定。结果:L2126表现出多药耐药特征,对碳青霉烯类、头孢菌素和氟喹诺酮类药物具有高水平耐药。基因组分析发现7个抗性基因,包括blaVIM-2和sul1。值得注意的是,blaVIM-2位于1类整合子(intI1-attI1- blaVIM-2-qacEΔ1-sul1)内,该整合子嵌入在tn402样平台上的约44 kb不可分质粒上。相邻的tni模块(tniR-tniQ-tniB-tniA)编码在相反的链上,表明它是转置平台的一部分,而不是整合子盒式阵列的一部分。S1-PFGE证实了~ 44 kb质粒的存在,硅分析提供了其遗传组织的示意图。BLAST分析表明,该质粒与之前在蒙氏假单胞菌中鉴定出的一个质粒具有高度的序列同源性,尽管这两个菌株属于不同的物种。结论:我们的研究结果表明,在亚洲p.a L2126中,一种新的~ 44 kb不可分型质粒上携带blaVIM-2可以促进碳青霉烯类耐药性的水平基因转移。该质粒与先前在蒙泰利假体中发现的一个质粒高度同源,表明它具有属内传播的潜力,对碳青霉烯类耐药性的传播构成重大威胁。
{"title":"Molecular characterization of blaVIM-2-carrying Pseudomonas asiatica L2126: identification of a ∼44 kb untypable plasmid with intra-genus dissemination potential","authors":"Jinhua Zhang ,&nbsp;Yi Liu ,&nbsp;Lei Fang ,&nbsp;Xinrui Wang ,&nbsp;Hao Xu ,&nbsp;Danfeng Lou","doi":"10.1016/j.jgar.2025.09.012","DOIUrl":"10.1016/j.jgar.2025.09.012","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to elucidate the molecular characteristics of a <em>bla</em><sub>VIM-2</sub>-carrying <em>Pseudomonas asiatica</em> isolate (L2126) from China and to characterize a ∼44 kb untypable plasmid harboring <em>bla</em><sub>VIM-2</sub>. We investigated the genetic context of <em>bla</em><sub>VIM-2</sub>, assessed the associated antimicrobial resistance determinants, and explored the role of this plasmid in mediating gene dissemination.</div></div><div><h3>Methods</h3><div>The isolate L2126 was recovered from an intestinal colonization sample in a patient from Hangzhou, China. Species identification was confirmed by average nucleotide identity (ANI) analysis. Hybrid whole-genome sequencing was performed using Illumina short-read and Oxford Nanopore long-read platforms. Genome assembly was conducted using Unicycler and annotated with Prokka. Antimicrobial resistance genes were identified via ResFinder and CARD. The genetic context of <em>bla</em><sub>VIM-2</sub> was delineated using IntegronFinder. Plasmid profiles were determined by S1-nuclease pulsed-field gel electrophoresis (S1-PFGE) and <em>in silico</em> replicon analysis.</div></div><div><h3>Results</h3><div>L2126 exhibited a multidrug-resistant profile with high-level resistance to carbapenems, cephalosporins, and fluoroquinolones. Genome analysis revealed 7 resistance genes, including <em>bla</em><sub>VIM-2</sub> and <em>sul1</em>. Notably, <em>bla</em><sub>VIM-2</sub> resides within a class 1 integron (<em>intI1-attI1-bla</em><sub>VIM-2</sub><em>-qacEΔ1-sul1</em>) embedded in a Tn<em>402</em>-like platform on a ∼44 kb untypable plasmid. The adjacent <em>tni</em> module (<em>tniR-tniQ-tniB-tniA</em>) is encoded on the opposite strand, indicating that it is part of the transposition platform rather than the integron cassette array. S1-PFGE confirmed the presence of the ∼44 kb plasmid, and <em>in silico</em> analysis provided a schematic representation of its genetic organization. BLAST analysis demonstrated that this plasmid shares high sequence homology with a plasmid previously identified in <em>Pseudomonas monteilii</em>, despite the two isolates belonging to different species.</div></div><div><h3>Conclusions</h3><div>Our findings demonstrate that the carriage of <em>bla</em><sub>VIM-2</sub> on a novel ∼44 kb untypable plasmid in <em>P. asiatica</em> L2126 could facilitate horizontal gene transfer of carbapenem resistance. The plasmid’s high homology to one previously identified in <em>P. monteilii</em> suggests that it has the potential for intra-genus dissemination, posing a significant threat to the spread of carbapenem resistance.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 173-175"},"PeriodicalIF":3.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of global antimicrobial resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1